InflaRx NV (IF0)
TG
The current IF0 market cap is 130.49M. The company's latest EPS is EUR -0.7246 and P/E is -3.24.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 400k | 222k | 54k | 20.16M | 63k |
Operating Income | -56.77M | -33.94M | -47.63M | -32.24M | -44.91M |
Net Income | -53.26M | -33.98M | -45.63M | -29.48M | -42.67M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 121.58M | 88.22M | 125.14M | 102.4M | 120.21M |
Total Liabilities | 14.43M | 10.35M | 19.86M | 14.05M | 17.63M |
Total Equity | 107.15M | 77.86M | 105.28M | 88.35M | 102.58M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -43.2M | -36.53M | -39.94M | -33.74M | -37.81M |
Investing | 20.34M | 21.36M | -25.95M | 19.36M | -17.7M |
Financing | -294k | 9.17M | 61.58M | 1.94M | 52.99M |
Market Cap | 130.49M |
Price to Earnings Ratio | -3.24 |
Price to Sales Ratio | 2.14k |
Price to Cash Ratio | 10.84 |
Price to Book Ratio | 1.35 |
Dividend Yield | - |
Shares Outstanding | 58.88M |
Average Volume (1 week) | 21.02k |
Average Volume (1 Month) | 41.24k |
52 Week Change | 43.71% |
52 Week High | 2.70 |
52 Week Low | 1.074 |
Spread (Intraday) | 0.09 (3.98%) |
Company Name | InflaRx NV |
Address |
winzerlaer jena 07745 |
Website | https://www.inflarx.de |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.